Gerresheimer Shares Rise on Sales Recovery

Gerresheimer reported a sequential recovery in second quarter revenue as demand for drug delivery devices boosted sales. The German packaging maker posted preliminary revenue of €578 million and reiterated expectations for a stronger second half.

Insights:
FILE PHOTO: Vials produced by Gerresheimer are displayed at the annual Drug, Chemical & Associated Technologies Association (DCAT) week in New York City, U.S. March 19, 2024. REUTERS/Patrick Wingrove/File Photo

Gerresheimer posted preliminary second-quarter revenue of €578 million ($656.09 million) on Wednesday morning, sending shares 8% higher in early trading. The sequential recovery in sales was driven by surging demand for drug delivery devices in Germany.